carbon-11-methionine and Rhabdoid-Tumor

carbon-11-methionine has been researched along with Rhabdoid-Tumor* in 1 studies

Other Studies

1 other study(ies) available for carbon-11-methionine and Rhabdoid-Tumor

Article	Year
Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI. Clinical nuclear medicine, 2012, Volume: 37, Issue:2 A 28-year-old man with headache, nausea, and decreased vision had a left parieto-occipital tumor demonstrated by MRI. Postradical resection and histology showed a solid mass containing rhabdoid cells, 10% positive for Ki-67. After completing chemotherapy and radiotherapy treatment, follow-up MRI revealed possible tumoral recurrence. Cerebral F-18 FDG PET revealed no pathologic uptake, and C-11 methionine PET showed a pathologic low uptake. These findings suggested recurrence of a mild-grade aggressiveness tumor, which was confirmed by a second neurosurgical resection. Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Rhabdoid Tumor	2012

Article

Year

Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI.

Clinical nuclear medicine, 2012, Volume: 37, Issue:2

A 28-year-old man with headache, nausea, and decreased vision had a left parieto-occipital tumor demonstrated by MRI. Postradical resection and histology showed a solid mass containing rhabdoid cells, 10% positive for Ki-67. After completing chemotherapy and radiotherapy treatment, follow-up MRI revealed possible tumoral recurrence. Cerebral F-18 FDG PET revealed no pathologic uptake, and C-11 methionine PET showed a pathologic low uptake. These findings suggested recurrence of a mild-grade aggressiveness tumor, which was confirmed by a second neurosurgical resection.

Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Rhabdoid Tumor

2012